Connect with us
European Gaming Congress 2024

Fintech PR

Bitcoin Price at 2011 Levels Returns as Bitcoin BSC Launch Provides Chance to Earn Free Bitcoin Clone Tokens

Published

on

bitcoin-price-at-2011-levels-returns-as-bitcoin-bsc-launch-provides-chance-to-earn-free-bitcoin-clone-tokens

NEW YORK, Sept. 5, 2023 /PRNewswire/ — Back in 2011, the Bitcoin price was $1, but today, following the launch of the Bitcoin BSC coin crypto presale on the BNB Smart Chain, buyers can acquire the token at a similarly low price and earn free Bitcoin clone tokens too.

Bitcoin, the world’s leading cryptocurrency, is struggling right now after bulls were trapped as enthusiasm at the prospect of the SEC spot bitcoin ETFs getting speedy approval receded. The price retraced below the $26k level, but it has been a different story for Bitcoin clone derivative coins.

During the past three months, for example, the Bitcoin Cash (BCH) fork from Bitcoin is up 73%, while Bitcoin has fallen -2.3% in the same time period.

Meanwhile, a similar staking-based bitcoin derivative coin to Bitcoin BSC, BTC20, which launched a month ago, is up 52%.

In fact, BTC20 hit an all-time (ATH) intraday high of $6, equating to a 688% 7x gain on its $1 presale and listing price.

Advertisement
Stake.com

Yet another bitcoin clone derivative, this time BTC2.0, rose to an ATH of $1.06 to register a return of 538x, although the price has retraced markedly from its peak.

Earn free Bitcoin clone tokens with stake-to-earn Bitcoin BSC coin

Bitcoin BSC aims to match, or beat, the success of all of these Bitcoin clone coins, and to achieve that end it has a not-so-secret weapon – staking.

While the performance of BTC2.0, not to be confused with BTC20, since its heights has been somewhat underwhelming, there has been more of a steady-as-she-goes approach by the likes of BTC20.

That’s probably largely down to the ballast effect of staking, which bears down on any selling pressure that may emerge at listing.

Advertisement
Stake.com

In this way, Bitcoin BSC seeks to emulate BTC20 by adopting a similar design and strategy, providing the price with a stable platform for takeoff.

Like BTC20, Bitcoin BSC has staking utility built into its design from the outset.

However, it should be noted that there is one important difference between Bitcoin BSC and BTC20 – Bitcoin BSC is a BEP-20 BNB Smart Chain-compliant token, and BTC20 is an ERC-20 Ethereum-compliant token – hence the BSC in the name.

Staking has been popular in the crypto DeFi space, but enthusiasm waned in the aftermath of high-profile implosions of staking ecosystems such as Terra Luna.

However, the attractiveness of transparent staking that has a clearly defined source of yield, unlike the opaque algorithms in use on Terra Luna, has not gone away.

Advertisement
Stake.com

With $BTCBSC, which runs on the BNB Smart Chain, the yield is paid out over a 120-year period, in line with Bitcoin block confirmations. Altogether, 69% of the total token supply is allocated to distribute as rewards.

Staking provides token holders with a way of earning token rewards in proportion to how many coins of the total pool they deposit into a staking smart contract and the time they choose to stake for.

It is this staking feature that will deliver price support while offering both positive capital returns and income yield to network participants.

Bitcoin BSC staking is operative now, even before the coin lists on the decentralized exchange PancakeSwap.

You can keep an eye on how many token holders are staking by visiting the real-time Bitcoin BSC staking dashboard.

Advertisement
Stake.com

Also, keep up-to-date with all project developments on X (formerly Twitter) and the Telegram channel.

You can snap up Bitcoin BSC at the low Bitcoin 2011 price of $0.99

$BTCBSC can be bought today for $ 0.99 – the same price the Bitcoin was at back in its 2011 early days, and a far cry from the $25,7000 it will cost you to purchase Bitcoin at today’s prices.

Bitcoin BSC’s comparatively low price means contributors to the presale could be sitting on substantial upside potential when the Bitcoin halving bull run takes off.

The four-yearly event that sees block rewards halved on the original Bitcoin network has previously ushered in mind-melting bull runs.

Advertisement
Stake.com

This halving is expected to have the effect of lifting all boats – especially the prices of quality Bitcoin clone derivative coins such as $BTCBSC.

Bitcoin BSC has the same total token supply as Bitcoin – 21 million. Of that total supply, 29% is up for grabs through the presale of 6,125,000 tokens, meaning BTCBSC has an initial market cap of $6,063,750.

Two percent of the supply is reserved for DEX liquidity provision to guarantee smooth trading at launch and beyond.

The remaining 14,455,000 BTCBSC tokens (69% of supply) is reserved for staking rewards, which are paid out every 10 minutes as new blocks are added to the chain.

At that token emission rate, the maximum supply will be reached in about 120 years – the same time frame as Bitcoin.

Advertisement
Stake.com

Presale and post-presale investors can buy and stake tokens at any time with a 7-day lock on withdrawals.

Bear in mind that because BTCBSC runs on the BNB Smart Chain, to buy and stake in the presale, you will need to use BNB for your purchase. However, those buying with ETH today can start staking after the presale ends.

https://twitter.com/Bitcoinbsctoken/status/1698803185727521146

Faster, cheaper, more powerful and expandable than other Bitcoin clones

Still, staking is not the only advantage BTCBSC has over Bitcoin and the larger-cap clone coins such as Bitcoin Cash, and Bitcoin SV.

Advertisement
Stake.com

For one thing, $BTCBSC uses a proof-of-stake protocol, which means it runs on a much more scalable blockchain that is also cheaper and more efficient to transact on.

Because BTCBSC is built on the BNB Smart Chain, transaction fees are less than $0.10, compared to around $10 on Bitcoin and approximately $20 on Ethereum, depending on network conditions.

Another advantage BTCBSC has is its fast transaction speeds, which are typically less than 5 seconds compared to 10 minutes for Bitcoin, BCH, and BSV.

BNB Smart Chain is capable of running applications, too, so there’s no limit to future development possibilities for Bitcoin BSC.

Bitcoin BSC has a lot going for it, and with only $3,960,000 being raised in the presale, demand is sure to be robust.

Advertisement
Stake.com

Crypto market prices are generally becalmed, but there are waters where the current is much healthier. In the Bitcoin derivative clone sector, there’s all to play for as far as bagging out 10x gains goes.

Get in early, and the rewards will not just accrue to long-term stakers earning a generous APY, but also to those who want the chance to access life-changing returns.

Photo: https://mma.prnewswire.com/media/2201818/Bitcoin_BSC_Coin_Launch.jpg

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/bitcoin-price-at-2011-levels-returns-as-bitcoin-bsc-launch-provides-chance-to-earn-free-bitcoin-clone-tokens-301918091.html

Advertisement
Stake.com
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024

Published

on

invitation-to-presentation-of-eqt-ab’s-q1-announcement-2024

STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

Advertisement
Stake.com

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision http://news.cision.com

Advertisement
Stake.com

https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826

The following files are available for download:

https://mb.cision.com/Main/87/3956826/2712771.pdf

Invitation to presentation of EQT AB’s Q1 Announcement 2024

https://news.cision.com/eqt/i/eqt-ab-group,c3285895

Advertisement
Stake.com

EQT AB Group

 

View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs

Published

on

kia-presents-roadmap-to-lead-global-electrification-era-through-evs,-hevs-and-pbvs
  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Advertisement
Stake.com

Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

Published

on

biovaxys-technology-corp.-provides-bi-weekly-mcto-status-update

VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

Advertisement
Stake.com

BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.

ON BEHALF OF THE BOARD

Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html

Advertisement
Stake.com
Continue Reading
Advertisement
Stake.com
Advertisement

Latest news

Trending